脑干听觉与视觉诱发电位对心脏骤停患者目标温度管理后的预后价值
该研究在目标温度管理注册队列中回顾性分析185例心脏骤停患者的185次体感诱发电位(SSEP)、172次脑干听觉诱发电位(BAEP)和178次视觉诱发电位(VEP),按N20、V、P100反应是否可辨分为缺失、存在或不确定,6个月神经预后按脑功能分级(CPC)1-2为良好、3-5为不良。结果:预后良好者均无SSEP、BAEP或VEP反应缺失;SSEP、BAEP、VEP反应缺失预测不良预后的敏感性分别为42.3%、9.4%、54.4%。联合VEP可提高单用SSEP及多模式评估的敏感性。结论:VEP预后价值与SSEP相当,BAEP因敏感性低应用受限,加测VEP可减少预后不确定性。
要点
- 预后良好(CPC 1-2)患者中无一例出现SSEP、BAEP或VEP反应缺失。
- SSEP、BAEP、VEP反应缺失预测不良预后的敏感性分别为42.3%(95%CI 33.7-51.3%)、9.4%(95%CI 4.6-16.7%)、54.4%(95%CI 46.0-62.5%)。
- 联合VEP使单用SSEP的敏感性从36.2%(95%CI 28.6-44.4%)提高到65.8%(95%CI 57.7-73.3%)。
- 联合VEP使SSEP联合脑干反射和脑CT的多模式评估敏感性从60.5%(95%CI 52.3-68.4%)提高到75.7%(95%CI 68.0-82.3%)。
- VEP预后价值与SSEP相当,BAEP因敏感性低(9.4%)应用受限,加测VEP可减少预后不确定性。
适用人群与场景
- 目标温度管理(TTM)的心脏骤停患者,来自TTM注册队列,共纳入185例患者、185次SSEP、172次BAEP和178次VEP。
诊断标准与关键阈值
- SSEP以N20、BAEP以V波、VEP以P100反应是否清晰可辨为判定标准,每类诱发电位分类为缺失、存在或不确定。
- 神经预后于6个月评估,按脑功能分级(CPC)二分:良好为CPC 1-2,不良为CPC 3-5。
研究设计与关键结果
- 回顾性分析TTM注册队列中185例心脏骤停患者,纳入185次SSEP、172次BAEP和178次VEP,评估N20、V、P100反应缺失对6个月不良神经预后(CPC 3-5)的预测价值。
- 预后良好(CPC 1-2)患者中无一例出现SSEP、BAEP或VEP反应缺失。
- SSEP、BAEP、VEP反应缺失预测不良预后的敏感性分别为42.3%(95%CI 33.7-51.3%)、9.4%(95%CI 4.6-16.7%)、54.4%(95%CI 46.0-62.5%)。
- 在总体队列中,加测VEP使单用SSEP的敏感性从36.2%(95%CI 28.6-44.4%)提高到65.8%(95%CI 57.7-73.3%)。
- 加测VEP使SSEP联合脑干反射和脑CT的多模式预后评估敏感性从60.5%(95%CI 52.3-68.4%)提高到75.7%(95%CI 68.0-82.3%)。
证据类型、等级与局限
- 证据类型:基于TTM注册队列的回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,VEP的预后价值与SSEP相当,加测VEP可减少预后不确定性。
- 作者指出,BAEP因敏感性低(9.4%)而应用受限。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: We analysed the prognostic value of somatosensory, brainstem auditory and visual evoked potentials (SSEPs, BAEPs and VEPs, respectively) for outcome prediction in cardiac arrest patients with targeted temperature management (TTM) and assessed whether BAEP and VEP measurements conferred added value to SSEP measurements.
METHODS: Cases with SSEPs and VEPs or BAEPs were reviewed in a TTM registry. We focused on whether the following responses were clearly discernible: N20 for SSEPs, V for BAEPs, and P100 for VEPs. Each type of evoked potential was classified as absent, present or indeterminable. Neurological outcomes after 6 months were dichotomized as good (Cerebral Performance Category [CPC] 1-2) or poor (CPC 3-5).
RESULTS: From 185 patients, 185 SSEPs, 172 BAEPs and 178 VEPs were included. None of the patients with a good outcome had absent SSEP, BAEP or VEP responses. Absent SSEP, BAEP and VEP responses yielded sensitivities of 42.3% (95% confidence interval [CI], 33.7-51.3%), 9.4% (95% CI, 4.6-16.7%) and 54.4% (95% CI, 46.0-62.5%) for poor outcomes, respectively. For the overall cohort, the addition of VEP measurements improved the sensitivities of single SSEP measurements (65.8% [95% CI, 57.7-73.3%] versus 36.2% [95% CI, 28.6-44.4%] and multimodal prognostication using SSEPs, brainstem reflex and brain computed tomography (75.7% [95% CI, 68.0-82.3%] versus 60.5% [95% CI, 52.3-68.4%]).
CONCLUSIONS: The prognostic value of VEPs was comparable to that of SSEPs, but the use of BAEPs was limited due to their low sensitivity. Additional VEP measurements can reduce prognostic uncertainty.
参考来源
- Lim JY, Oh SH, Park KN, et al. Prognostic value of brainstem auditory and visual evoked potentials in cardiac arrest patients with targeted temperature management. Resuscitation. 2021. PMID: 33964333. doi:10.1016/j.resuscitation.2021.04.024
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。